Core Scientific stock falls nearly 4% as insider sales and bearish technicals weigh ahead of earnings report

Traders Union
All News
Stocks
Core scientific slides 3.9% today

Highlights

Core Scientific is scheduled to report third quarter 2026 earnings before market open on November 5.
Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 shares under a pre-planned program but retains 700,000 shares in a trust.
Shares of Core Scientific last traded at $14.42, with technical signals showing continued bearish pressure and a projected five-day range of $13.23 to $15.61.

Earnings anticipation shapes flows amid insider divestment and retained stake

Core Scientific is set to release its third quarter 2026 earnings report before the market opens on November 5. In recent corporate activity, Chief Legal and Administrative Officer Todd M. Duchene sold 10,000 shares on October 26, 2026, under a Rule 10b5-1 trading plan adopted in December 2025. Duchene continues to hold 700,000 shares through a trust he administers.

Anton Kharitonov, expert at Traders Union, sees mounting risks for Core Scientific ahead of earnings. Sellers remain dominant as prices persist below key moving averages, casting doubt on near-term recovery prospects. Corporate insiders have sold shares recently, reinforcing a cautious bias among market participants. Despite the share sale, the technical outlook stays negative, with momentum and oscillator alignment pointing to further downside. "Core Scientific faces continued headwinds — traders should avoid chasing upside until a clear reversal emerges on both technical and sentiment fronts."

Viktoras Karapetjanc, expert at Traders Union, highlights Core Scientific's earnings catalyst as a potential turning point. He notes that the large trust-held position suggests alignment with shareholder interests despite recent planned insider sales. The upcoming report may attract renewed attention to the stock’s opportunity set. "I believe a breakout above $14.77 opens the door for further growth — investors should be alert for positive earnings momentum that can recharge the bullish structure."

Sholanke Dele, market strategist, adopts a skeptical view on Core Scientific. He underscores recent volatility and persistent selling, with the gap down move reflecting weak sentiment. The intraday overbought signal despite an overall bearish picture points to confused short-term direction. "With deteriorating momentum and pressure on support at $14.39, I’d wait for stabilization before considering any long exposure."

Bearish trend confirmed as momentum and oscillators clash near support

Core Scientific is trading below its 20-day, 50-day, and 200-day moving averages, with the last traded price at $14.42, indicating sellers remain in control across short-, medium-, and long-term trends. The near-term floor is $14.39 and resistance is close by at $14.77, with distant trend levels confirming the prevailing bearish alignment. Momentum signals are negative, with both the Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) giving sell signals. The Relative Strength Index (RSI) sits at 48.77 and forecasts a sell, while the Stochastic RSI is at 100, highlighting an overbought condition. Commodity Channel Index (CCI) and Awesome Oscillator (AO) both read neutral. Bull/Bear Power (BBP) is positive at 0.7, indicating buyers have an edge intraday, but its overbought warning tempers bullish conviction. The stock is down $0.585 or 3.9% on the session, opening downside with a gap of 3.13%. It trades near the day's low and shows intraday volatility of 4.31%, reflecting persistent pressure after the open. There are some conflicting signals between momentum and oscillator readings, suggesting mixed short-term sentiment.

Previously, analysts noted that Core Scientific shares were exhibiting mixed technical signals and heightened volatility ahead of earnings, with a balanced scenario between consolidation and the potential for a breakout. The current analysis reinforces a bearish technical structure and highlights $14.39 as the key level to watch for downside risk in the sessions ahead.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.